Description

TIRZEPATIDE INFOR MATION (GLP-1 + GIP)

• BENEFITS
• Decreased appetite and cravings
• Weight loss
• Clinical trials showed 15% to 30% weight loss depending on doses
• Each individual loses weight at their own rate
• Compounded formulas are compounded with medication to help alleviate side effects of nausea
• Injections are once weekly
• You can repeat program as many times as you wish

COMMON SIDE EFFECTS

• Nausea
• Constipation
• Upset stomach
• Indigestion

RISK OF THYROID C-CELL TUMORS

• If you or any family member has been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer you should not take Tirzepatide

INFORMATION

• Tirzepatide is a combination glucagon-like peptide 1 (GLP-1) receptor AND glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that acts on areas of brain that regulate food intake and appetite. GIP pathwaty also regulates insulin levels. 2,539 adult clinical trial showed weight loss from 15% to 35% weight loss versus placebo group.